Dearbump, a UK-based maternal health company, has officially launched a new pregnancy app designed to provide real-time health tracking and integrated access to midwives. The app aims to address significant gaps in maternal healthcare by empowering women with more control over their pregnancy journey. According to the All-Party Parliamentary Group (APPG) on Birth Trauma, up to 79% of women experience some form…
Carrot Fertility, a leading company in fertility and family-building care, has launched CarrotMatch for maternity, a new pregnancy navigation system designed to connect members with the best pregnancy providers for their specific needs. The tool leverages a unique dataset that evaluates providers across more than 200 metrics, ensuring that members are matched with the highest quality and most cost-effective care available. CarrotMatch…
Sonio, the medtech company specializing in women’s and children’s health, has officially been acquired by Samsung Medison, a global medical equipment company affiliated with Samsung Electronics, following the approval of the French Ministry of the Economy and Finance. This acquisition marks a significant milestone in the global expansion of Sonio’s innovative healthcare solutions, aimed at enhancing maternal and child health worldwide. The acquisition…
A new study conducted by Quest Diagnostics in collaboration with the University of Alabama has revealed significant gaps in the testing and treatment of sexually transmitted infections (STIs) among pregnant women in the United States. The study, titled Chlamydia and gonorrhea testing in pregnancy: Time to improve adherence and update recommendations, was published in the ‘Journal of Lower Genital Tract Disease’ and…
Needed, a company dedicated to improving perinatal nutrition, has launched Needed Academy, an Instagram-based educational program designed to address the critical need for accurate information on fertility, pregnancy, and postpartum health. Needed Academy is an educational platform specifically created for health practitioners, advocates, and influencer partners associated with Needed. The program responds to the widespread issue of outdated and inaccurate health information…
DiaMedica Therapeutics, a clinical-stage biopharmaceutical company focused on novel treatments for severe ischemic diseases, has announced the initiation of a Phase 2 trial for their preeclampsia treatment, DM199. This announcement came alongside their second quarter 2024 financial results and business update. Preeclampsia (PE) is a serious pregnancy complication characterized by high blood pressure and damage to organ systems, often affecting the kidneys…
Johnson & Johnson has announced significant findings from their Phase 2 UNITY study of nipocalimab for the treatment of pregnant individuals at high risk for early onset severe hemolytic disease of the fetus and newborn (HDFN). The results, published in The New England Journal of Medicine, indicate that nipocalimab can delay or prevent severe fetal anemia and improve birth outcomes. HDFN occurs…
Babylist, a platform trusted by millions of growing families for its wide range of products and services across commerce, media, and health, has announced an expansion of its health offerings. This move aims to provide expecting and new parents with easier and more transparent access to health and wellness products during pregnancy and postpartum. The expansion includes broader coverage with breast pump…
